Company & Sponsor Intelligence
AstraZeneca
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials12
Recruiting0
Completed12
Countries7
Therapeutic footprint
alzheimersdepressionparkinsonsschizophrenia
Indexed studies
NCT02040987AZD3293 Thorough QT Study in Healthy Male Volunteers
alzheimers · United StatesPHASE1
alzheimers · United StatesPHASE1
NCT00687141Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects
alzheimers · SwedenPHASE1
alzheimers · SwedenPHASE1
NCT03272165Single Ascending Dose Study of MEDI1341 in Healthy Volunteers
parkinsons · United StatesPHASE1
parkinsons · United StatesPHASE1
NCT02126514A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293
alzheimers · United StatesPHASE1
alzheimers · United StatesPHASE1
NCT00206102A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder
schizophrenia · United StatesPHASE4
schizophrenia · United StatesPHASE4
NCT00690248Depressive Symptoms in Acute Manic Episode
depression · SpainCOMPLETED
depression · SpainCOMPLETED
NCT00621647Seroquel- Agitation Associated With Dementia
alzheimers · PHASE3
alzheimers · PHASE3
NCT01202617Seroquel XR in the Long Term Treatment of Schizophrenia
schizophrenia · HungaryCOMPLETED
schizophrenia · HungaryCOMPLETED
NCT00779506Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR)
schizophrenia · South KoreaPHASE4
schizophrenia · South KoreaPHASE4
NCT02051335Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults
alzheimers · United KingdomPHASE1
alzheimers · United KingdomPHASE1
NCT00883493Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression
depression · ArgentinaPHASE3
depression · ArgentinaPHASE3
NCT00689559Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy Subjects
alzheimers · SwedenPHASE1
alzheimers · SwedenPHASE1
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →